{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:17:06Z","timestamp":1787728626217,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.intimp.2023.110664","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T22:17:13Z","timestamp":1689977833000},"page":"110664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Coadministration of 3\u20325-dimaleamylbenzoic acid and quercetin decrease pulmonary fibrosis in a systemic sclerosis model"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9077-2159","authenticated-orcid":false,"given":"Edilburga","family":"Reyes-Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma Aurora","family":"Ram\u00edrez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovito Cesar","family":"Santos-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Vel\u00e1zquez-Enr\u00edquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1127-0095","authenticated-orcid":false,"given":"Gabriela","family":"Carrasco-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00fal","family":"Villa-Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3416-6917","authenticated-orcid":false,"given":"Rafael","family":"Balti\u00e9rrez-Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica Roc\u00edo","family":"V\u00e1squez-Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110664_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110664_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/4569826","article-title":"Systemic sclerosis pathogenesis and emerging therapies, beyond the fibroblast","volume":"2019","author":"Sierra-Sep\u00falveda","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.intimp.2023.110664_b0015","article-title":"Innovations in the assessment of primary and secondary Raynaud\u2019s phenomenon","volume":"10","author":"Ruaro","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110664_b0020","doi-asserted-by":"crossref","DOI":"10.4081\/reumatismo.2013.186","article-title":"Prospective capillaroscopy-based study on transition from primary to secondary Raynaud\u2019s phenomenon: preliminary results","volume":"65","author":"Bernero","year":"2013","journal-title":"Reumatismo"},{"key":"10.1016\/j.intimp.2023.110664_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109723","article-title":"Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis","volume":"116","author":"Bellamri","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.110664_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.588753","article-title":"Correlation between skin and affected organs in 52 sclerodermic patients followed in a diseases management team: development of a risk prediction model of organ-specific complications","volume":"12","author":"Cozzani","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110664_b0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CLEP.S191418","article-title":"Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease","volume":"11","author":"Bergamasco","year":"2019","journal-title":"Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110664_b0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.patbio.2015.03.003","article-title":"Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis","volume":"63","author":"Hua-Huy","year":"2015","journal-title":"Pathol. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110664_b0045","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.110664_b0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5301\/jsrd.5000240","article-title":"The mighty fibroblast and its utility in scleroderma research","volume":"2","author":"Garrett","year":"2017","journal-title":"J. Scleroderma Relat. Disord."},{"issue":"8","key":"10.1016\/j.intimp.2023.110664_b0055","doi-asserted-by":"crossref","first-page":"L736","DOI":"10.1152\/ajplung.00210.2013","article-title":"Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease","volume":"306","author":"Lee","year":"2014","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110664_b0060","doi-asserted-by":"crossref","DOI":"10.7555\/JBR.31.20170034","article-title":"Transforming growth factor-\u03b2 signaling in systemic sclerosis","volume":"32","author":"Nolan","year":"2018","journal-title":"J. Biomed. Res."},{"issue":"10","key":"10.1016\/j.intimp.2023.110664_b0065","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/annrheumdis-2018-214865","article-title":"Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease","volume":"78","author":"Valenzi","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2023.110664_b0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1165\/rcmb.2017-0289OC","article-title":"Quercetin enhances ligand-induced apoptosis in senescent idiopathic pulmonary fibrosis fibroblasts and reduces lung fibrosis in vivo","volume":"60","author":"Hohmann","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110664_b0075","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1164\/arrd.1985.131.4.612","article-title":"Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis","volume":"131","author":"Rossi","year":"1985","journal-title":"Am. Rev. Respir. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2023.110664_b0080","article-title":"Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis","volume":"13","author":"Zheng","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2023.110664_b0085","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.15419\/bmrat.v6i1.518","article-title":"Effect of Thalidomide on Cox-2 expression in bleomycin-induced pulmonary fibrosis in mice","volume":"6","author":"Moayeri","year":"2019","journal-title":"Biomed. Res. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2023.110664_b0090","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1590\/S1806-37132013000600008","article-title":"Immunohistochemical and morphometric evaluation of COX1 and COX-2 in the remodeled lung in idiopathic pulmonary fibrosis and systemic sclerosis","volume":"39","author":"Parra","year":"2013","journal-title":"J. Bras. Pneumol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110664_b0095","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1590\/1414-431X20133061","article-title":"Morphometric evaluation of nitric oxide synthase isoforms and their cytokine regulators predict pulmonary dysfunction and survival in systemic sclerosis","volume":"46","author":"Parra","year":"2013","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"8","key":"10.1016\/j.intimp.2023.110664_b0100","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3899\/jrheum.090915","article-title":"Increased alveolar concentration of nitric oxide is related to serum-induced lung fibroblast proliferation in patients with systemic sclerosis","volume":"37","author":"Hua-Huy","year":"2010","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110664_b0105","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1165\/rcmb.2010-0113OC","article-title":"Nuclear \u03b2-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation","volume":"45","author":"Lam","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110664_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14612-5","article-title":"Involvement of ER stress, PI3K\/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis","volume":"7","author":"Hsu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.110664_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101122","article-title":"Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis","volume":"25","author":"Doridot","year":"2019","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110664_b0120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/14397595.2016.1206510","article-title":"Oxidative stress markers in blood in systemic sclerosis: a meta-analysis","volume":"27","author":"Luo","year":"2016","journal-title":"Mod. Rheumatol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110664_b0125","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1111\/jcmm.13630","article-title":"Oxidative stress in the pathogenesis of systemic scleroderma: an overview","volume":"22","author":"Vona","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110664_b0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/bmc-2021-0023","article-title":"NADPH-derived ROS generation drives fibrosis and endothelial-to-mesenchymal transition in systemic sclerosis: potential cross talk with circulating miRNAs","volume":"13","author":"Posadino","year":"2022","journal-title":"Biomol. Concepts"},{"issue":"8","key":"10.1016\/j.intimp.2023.110664_b0135","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.4049\/jimmunol.1801232","article-title":"Involvement of GPx4-regulated lipid peroxidation in idiopathic pulmonary fibrosis pathogenesis","volume":"203","author":"Tsubouchi","year":"2019","journal-title":"J. Immunol."},{"issue":"14","key":"10.1016\/j.intimp.2023.110664_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147943","article-title":"3\u20325-Dimaleamylbenzoic acid attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"23","author":"Gonz\u00e1lez-Garc\u00eda","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.110664_b0145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.taap.2017.10.001","article-title":"The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin","volume":"336","author":"Veith","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110664_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2734976","article-title":"Cytotoxicity, oxidative stress, cell cycle arrest, and mitochondrial apoptosis after combined treatment of hepatocarcinoma cells with maleic anhydride derivatives and quercetin","volume":"2017","author":"Carrasco-Torres","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2023.110664_b0155","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2023.110664_b0160","article-title":"Baicalin alleviates bleomycin-induced pulmonary fibrosis and fibroblast proliferation in rats via the PI3K\/AKT signaling pathway","author":"Zhao","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2023.110664_b0165","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2010.05.019","article-title":"A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis","volume":"642","author":"Baowen","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110664_b0170","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00296-016-3636-7","article-title":"Interstitial lung disease in systemic sclerosis: current and future treatment","volume":"37","author":"Giacomelli","year":"2017","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.intimp.2023.110664_b0175","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/rheumatology\/keab615","article-title":"The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19","volume":"61","author":"Orlandi","year":"2022","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.intimp.2023.110664_b0180","doi-asserted-by":"crossref","first-page":"L376","DOI":"10.1152\/ajplung.00311.2019","article-title":"Modeling pulmonary fibrosis through bleomycin delivered by osmotic minipump: a new histomorphometric method of evaluation","volume":"318","author":"Ravanetti","year":"2020","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110664_b0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97728-z","article-title":"SSC-ILD mouse model induced by osmotic minipump delivered bleomycin: effect of Nintedanib","volume":"11","author":"Ravanetti","year":"2021","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2023.110664_b0190","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1210\/en.2004-0959","article-title":"Minireview: cyclin D1: normal and abnormal functions","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.intimp.2023.110664_b0195","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-7-88","article-title":"RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis","volume":"7","author":"Watts","year":"2006","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.110664_b0200","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/PAI.0000000000000692","article-title":"Evaluation of cyclin D1 as a discriminatory immunohistochemical biomarker for idiopathic pulmonary fibrosis","volume":"27","author":"Wei","year":"2019","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110664_b0205","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/jbcr\/irab100","article-title":"Synergistic effects of quercetin-modified silicone gel sheet in scar treatment","volume":"43","author":"Jin","year":"2022","journal-title":"J. Burn Care Res."},{"issue":"6","key":"10.1016\/j.intimp.2023.110664_b0210","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1139\/bcb-2017-0302","article-title":"Quercetin ameliorates pulmonary fibrosis by inhibiting SphK1\/S1P signaling","volume":"96","author":"Zhang","year":"2018","journal-title":"Biochem. Cell Biol."},{"issue":"3\u20134","key":"10.1016\/j.intimp.2023.110664_b0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000490417","article-title":"Quercetin shows the pharmacological activity to simultaneously downregulate the inflammatory and fibrotic responses to tissue injury in association with its ability to target multi-kinases","volume":"102","author":"Song","year":"2018","journal-title":"Pharmacology"},{"key":"10.1016\/j.intimp.2023.110664_b0220","first-page":"99","article-title":"Quercetin-3-Rutinoside alleviates radiation-induced lung inflammation and fibrosis via regulation of NF-\u03baB\/TGF-\u03b21 signaling","author":"Verma","year":"2022","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.intimp.2023.110664_b0225","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1021\/jm950872p","article-title":"Design, synthesis, and biochemical evaluation of N-substituted maleimides as inhibitors of prostaglandin endoperoxide synthases","volume":"39","author":"Kalgutkar","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2023.110664_b0230","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.intimp.2017.03.029","article-title":"Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-\u043aB\/I\u043aB\u03b1, p38 MAPK, and Bcl-2\/Bax signaling","volume":"47","author":"Wang","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110664_b0235","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/9\/3\/036007","article-title":"Increased exhaled nitric oxide precedes lung fibrosis in two murine models of systemic sclerosis","volume":"9","author":"Hua-Huy","year":"2015","journal-title":"J. Breath Res."},{"issue":"3","key":"10.1016\/j.intimp.2023.110664_b0240","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2249.2003.02320.x","article-title":"Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features","volume":"134","author":"Takagi","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110664_b0245","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1017\/S0007114515002597","article-title":"Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice","volume":"114","author":"Impellizzeri","year":"2015","journal-title":"Br. J. Nutr."},{"issue":"12","key":"10.1016\/j.intimp.2023.110664_b0250","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1007\/s11010-021-04244-9","article-title":"Involvement of 4-hydroxy-2-nonenal in the pathogenesis of pulmonary fibrosis","volume":"476","author":"Reyes-Jim\u00e9nez","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.intimp.2023.110664_b0255","doi-asserted-by":"crossref","first-page":"11789","DOI":"10.1074\/jbc.M311184200","article-title":"Role of mitogen-activated protein kinases in 4-hydroxy-2-nonenal-induced actin remodeling and barrier function in endothelial cells","volume":"279","author":"Usatyuk","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2023.110664_b0260","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.3892\/mmr.2017.6546","article-title":"Sulforaphane prevents bleomycin-induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2-related factor-2 activation","volume":"15","author":"Yan","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2023.110664_b0265","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1164\/rccm.2110101","article-title":"4-hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease","volume":"166","author":"Rahman","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.intimp.2023.110664_b0270","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.freeradbiomed.2012.05.016","article-title":"Transforming growth factor \u03b2 suppresses glutamate\u2013cysteine ligase gene expression and induces oxidative stress in a lung fibrosis model","volume":"53","author":"Liu","year":"2012","journal-title":"Free Radic. Biol. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692300989X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692300989X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:28:11Z","timestamp":1736432891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692300989X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":54,"alternative-id":["S156757692300989X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110664","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coadministration of 3\u20325-dimaleamylbenzoic acid and quercetin decrease pulmonary fibrosis in a systemic sclerosis model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110664"}}